120 related articles for article (PubMed ID: 35301782)
1. Microbial translocation is associated with advanced liver fibrosis among people with HIV.
He J; Shi R; Duan S; Ye R; Yang Y; Wang J; Zu Z; Tang R; Gao J; Liu X; He N
HIV Med; 2022 Oct; 23(9):947-958. PubMed ID: 35301782
[TBL] [Abstract][Full Text] [Related]
2. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
[TBL] [Abstract][Full Text] [Related]
3. Plasma Inflammatory Biomarkers Associated with Advanced Liver Fibrosis in HIV-HCV-Coinfected Individuals.
Chen X; Liu X; Duan S; Tang R; Zhou S; Ye R; Yang Y; Wang J; Yao S; He N
Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33348839
[TBL] [Abstract][Full Text] [Related]
4. Markers of microbial translocation during pregnancy: differences among HIV+ women of African and European provenance.
Baroncelli S; Galluzzo CM; Molinari A; Pirillo MF; Cavalli A; Negri E; Floridia M; Degli Antoni A
J Infect Dev Ctries; 2020 Feb; 14(2):184-190. PubMed ID: 32146453
[TBL] [Abstract][Full Text] [Related]
5. sCD14 is not a bona-fide biomarker of microbial translocation in HIV-1-infected Africans living in Belgium.
De Voeght A; Maes N; Moutschen M
AIDS; 2016 Mar; 30(6):921-4. PubMed ID: 26636930
[TBL] [Abstract][Full Text] [Related]
6. Immune activation and microbial translocation in liver disease progression in HIV/hepatitis co-infected patients: results from the Icona Foundation study.
Marchetti G; Cozzi-Lepri A; Tincati C; Calcagno A; Ceccherini-Silberstein F; De Luca A; Antinori A; Castagna A; Puoti M; Monforte Ad;
BMC Infect Dis; 2014 Feb; 14():79. PubMed ID: 24520976
[TBL] [Abstract][Full Text] [Related]
7. Effects of Co-Trimoxazole on Microbial Translocation in HIV-1-Infected Patients Initiating Antiretroviral Therapy.
Vesterbacka J; Barqasho B; Häggblom A; Nowak P
AIDS Res Hum Retroviruses; 2015 Aug; 31(8):830-6. PubMed ID: 26059763
[TBL] [Abstract][Full Text] [Related]
8. Long-term Use of Proton Pump Inhibitors Is Associated With Increased Microbial Product Translocation, Innate Immune Activation, and Reduced Immunologic Recovery in Patients With Chronic Human Immunodeficiency Virus-1 Infection.
Serpa JA; Rueda AM; Somasunderam A; Utay NS; Lewis D; Couturier JP; Breaux KG; Rodriguez-Barradas M
Clin Infect Dis; 2017 Oct; 65(10):1638-1643. PubMed ID: 29020215
[TBL] [Abstract][Full Text] [Related]
9. Circulating sCD14 is associated with virological response to pegylated-interferon-alpha/ribavirin treatment in HIV/HCV co-infected patients.
Marchetti G; Nasta P; Bai F; Gatti F; Bellistrì GM; Tincati C; Borghi F; Carosi G; Puoti M; Monforte Ad
PLoS One; 2012; 7(2):e32028. PubMed ID: 22363790
[TBL] [Abstract][Full Text] [Related]
10. HIV Infection, HCV Coinfection, and Alcohol Use: Associations with Microbial Translocation and Immune Activation.
Monnig MA; Cohen R; Ramratnam B; McAdams M; Tashima K; Monti PM
Alcohol Clin Exp Res; 2019 Jun; 43(6):1126-1134. PubMed ID: 30908642
[TBL] [Abstract][Full Text] [Related]
11. Immune Activation and Microbial Translocation Markers in HIV-Exposed Uninfected Malawian Infants in the First Year of Life.
Baroncelli S; Galluzzo CM; Liotta G; Andreotti M; Mancinelli S; Mphwere R; Bokola E; Amici R; Marazzi MC; Palombi L; Palmisano L; Giuliano M
J Trop Pediatr; 2019 Dec; 65(6):617-625. PubMed ID: 31006009
[TBL] [Abstract][Full Text] [Related]
12. Serum lipopolysaccharide-binding protein and soluble CD14 are markers of disease activity in patients with Crohn's disease.
Lakatos PL; Kiss LS; Palatka K; Altorjay I; Antal-Szalmas P; Palyu E; Udvardy M; Molnar T; Farkas K; Veres G; Harsfalvi J; Papp J; Papp M
Inflamm Bowel Dis; 2011 Mar; 17(3):767-77. PubMed ID: 20865702
[TBL] [Abstract][Full Text] [Related]
13. Bacterial translocation in HIV-infected patients with HCV cirrhosis: implication in hemodynamic alterations and mortality.
de Oca Arjona MM; Marquez M; Soto MJ; Rodriguez-Ramos C; Terron A; Vergara A; Arizcorreta A; Fernandez-Gutierrez C; Giron-González JA
J Acquir Immune Defic Syndr; 2011 Apr; 56(5):420-7. PubMed ID: 21266909
[TBL] [Abstract][Full Text] [Related]
14. Alcohol use predicts elevation in inflammatory marker soluble CD14 in men living with HIV.
Monnig MA; Kahler CW; Cioe PA; Tucker L; Monti PM; Mayer KH; Ramratnam B
AIDS Care; 2016 Nov; 28(11):1434-40. PubMed ID: 27242060
[TBL] [Abstract][Full Text] [Related]
15. Discordant patterns of bacterial translocation markers and implications for innate immune imbalances in schizophrenia.
Severance EG; Gressitt KL; Stallings CR; Origoni AE; Khushalani S; Leweke FM; Dickerson FB; Yolken RH
Schizophr Res; 2013 Aug; 148(1-3):130-7. PubMed ID: 23746484
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of liver fibrosis: concordance analysis between noninvasive scores (APRI and FIB-4) evolution and predictors in a cohort of HIV-infected patients without hepatitis C and B infection.
Mendeni M; Focà E; Gotti D; Ladisa N; Angarano G; Albini L; Castelnuovo F; Carosi G; Quiros-Roldan E; Torti C
Clin Infect Dis; 2011 May; 52(9):1164-73. PubMed ID: 21467023
[TBL] [Abstract][Full Text] [Related]
17. Microbial translocation and liver disease progression in women coinfected with HIV and hepatitis C virus.
French AL; Evans CT; Agniel DM; Cohen MH; Peters M; Landay AL; Desai SN
J Infect Dis; 2013 Aug; 208(4):679-89. PubMed ID: 23687224
[TBL] [Abstract][Full Text] [Related]
18. A 12 week longitudinal study of microbial translocation and systemic inflammation in undernourished HIV-infected Zambians initiating antiretroviral therapy.
Canipe A; Chidumayo T; Blevins M; Bestawros M; Bala J; Kelly P; Filteau S; Shepherd BE; Heimburger DC; Koethe JR
BMC Infect Dis; 2014 Sep; 14():521. PubMed ID: 25266928
[TBL] [Abstract][Full Text] [Related]
19. Menopause and Estrogen Associations With Gut Barrier, Microbial Translocation, and Immune Activation Biomarkers in Women With and Without HIV.
Peters BA; Hanna DB; Xue X; Weber K; Appleton AA; Kassaye SG; Topper E; Tracy RP; Guillemette C; Caron P; Tien PC; Qi Q; Burk RD; Sharma A; Anastos K; Kaplan RC
J Acquir Immune Defic Syndr; 2024 Jul; 96(3):214-222. PubMed ID: 38905473
[TBL] [Abstract][Full Text] [Related]
20. The association between plasma endotoxin, endotoxin pathway proteins and outcome after ischemic stroke.
Klimiec E; Pasinska P; Kowalska K; Pera J; Slowik A; Dziedzic T
Atherosclerosis; 2018 Feb; 269():138-143. PubMed ID: 29353229
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
